TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

CUSIP: 89854M101

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Shares outstanding
52,382,313
Total 13F shares
34,291,369
Share change
+2,378,550
Total reported value
$272,339,183
Price per share
$7.94
Number of holders
65
Value change
+$19,079,789
Number of buys
38
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 89854M101?
CUSIP 89854M101 identifies TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q1 2024

As of 31 Mar 2024, TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,291,369 shares. The largest 10 holders included Lynx1 Capital Management LP, EcoR1 Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, BAKER BROS. ADVISORS LP, Propel Bio Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Deer Management Co. LLC, and Alphabet Inc.. This page lists 65 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.